Vaxcyte, Inc.
PCVX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001649094
In the last 90 days, Vaxcyte, Inc. insiders filed 0 open-market purchases and 8 sales; 331 institutions reported holding it in 13F filings for Q2 2026, worth $9.71B in total; Maverick Capital is the only superinvestor holding it.
13F holders, Q3 2022
Institutional positions in Vaxcyte, Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 126
- +20 vs. Q2 2022
- Shares held
- 56.5M
- +5.05M (+9.8%) vs. Q2 2022
- Total value
- $1.36B
- +$237.0M (+21.2%) vs. Q2 2022
- New holders
- 26
- 50 more added
- Sold out
- 6
- 28 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PCVX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 331 | $9.71B |
| Q1 2026 | 336 | $9.44B |
| Q4 2025 | 295 | $6.81B |
| Q3 2025 | 285 | $5.09B |
| Q2 2025 | 294 | $4.80B |
| Q1 2025 | 315 | $5.88B |
| Q4 2024 | 323 | $11.5B |
| Q3 2024 | 329 | $15.6B |
| Q2 2024 | 265 | $9.26B |
| Q1 2024 | 251 | $8.13B |
| Q4 2023 | 223 | $6.47B |
| Q3 2023 | 202 | $5.17B |
| Q2 2023 | 197 | $5.00B |
| Q1 2023 | 188 | $3.15B |
| Q4 2022 | 198 | $3.91B |
| Q3 2022 | 126 | $1.36B |
| Q2 2022 | 106 | $1.12B |
| Q1 2022 | 88 | $1.20B |
| Q4 2021 | 87 | $1.06B |
| Q3 2021 | 78 | $1.10B |
| Q2 2021 | 75 | $972.7M |
| Q1 2021 | 74 | $869.2M |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Vaxcyte, Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Point72 Asset Management, L.P. | 422,800 | $10.1M | 0.04% | +422,800 | New |
| Northern Trust Corp | 483,892 | $11.6M | 0.00% | +19,555+4.2% | Added |
| Goldman Sachs Group Inc | 487,883 | $11.7M | 0.00% | +134,502+38.1% | Added |
| Capital Research Global Investors | 514,856 | $12.7M | 0.00% | +514,856 | New |
| Driehaus Capital Management LLC | 583,606 | $14.0M | 0.21% | +35,416+6.5% | Added |
| Great Point Partners LLC | 600,000 | $14.4M | 3.47% | −385,153−39.1% | Reduced |
| Avidity Partners Management LP | 628,700 | $15.1M | 0.33% | +628,700 | New |
| Kynam Capital Management, LP | 698,638 | $16.8M | 3.54% | −25,143−3.5% | Reduced |
| OrbiMed Advisors LLC | 717,900 | $17.2M | 0.34% | −795,759−52.6% | Reduced |
| Pivotal bioVenture Partners Investment Advisor LLC | 776,039 | $18.6M | 6.81% | −56,127−6.7% | Reduced |
| Millennium Management LLC | 786,322 | $18.9M | 0.02% | +220,206+38.9% | Added |
| Novo Holdings A/S | 823,705 | $19.8M | 0.95% | 00.0% | Unchanged |
| Citadel Advisors LLC | 832,867 | $20.0M | 0.02% | −170,119−17.0% | Reduced |
| National Bank of Canada | 885,538 | $21.3M | 0.12% | +885,538 | New |
| Geode Capital Management, LLC | 894,786 | $21.5M | 0.00% | +115,091+14.8% | Added |
| Frazier Life Sciences Management, L.P. | 1,547,405 | $37.1M | 2.86% | −240,000−13.4% | Reduced |
| Wellington Management Group LLP | 1,748,921 | $42.0M | 0.01% | +1,619,700+1,253.4% | Added |
| Medicxi Ventures Management (Jersey) Ltd | 1,887,478 | $45.3M | 18.86% | 00.0% | Unchanged |
| State Street Corp | 1,993,036 | $47.8M | 0.00% | +137,392+7.4% | Added |
| TPG GP A, LLC | 3,285,504 | $78.9M | 1.29% | −381,921−10.4% | Reduced |
| BlackRock Inc. | 3,492,321 | $83.8M | 0.00% | +220,691+6.7% | Added |
| Abingworth LLP | 4,168,718 | $100.0M | 34.21% | 00.0% | Unchanged |
| Vanguard Group Inc | 4,452,145 | $106.9M | 0.00% | +496,227+12.5% | Added |
| Janus Henderson Group PLC | 4,537,751 | $108.9M | 0.08% | +313,264+7.4% | Added |
| Ra Capital Management, L.P. | 4,581,203 | $109.9M | 2.35% | 00.0% | Unchanged |
| FMR LLC | 8,897,197 | $213.5M | 0.02% | +383,791+4.5% | Added |
| Ikarian Capital, LLC | 0 | $0 | 0.00% | −225,991−100.0% | Sold out |
| Gyon Technologies Capital Management, LP | 0 | $0 | 0.00% | −27,105−100.0% | Sold out |
| Boothbay Fund Management, LLC | 0 | $0 | 0.00% | −22,733−100.0% | Sold out |
| Trexquant Investment LP | 0 | $0 | 0.00% | −16,851−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −13,820−100.0% | Sold out |
| Voloridge Investment Management, LLC | 0 | $0 | 0.00% | −12,475−100.0% | Sold out |